Cytoskeleton-dependent activation of the inducible nitric oxide synthase in cultured aortic smooth muscle cells

Keyphrases

• Inducible Nitric Oxide Synthase 100%
• Cytoskeleton 100%
• Human Aortic Smooth muscle Cells (HASMCs) 100%
• Nitric Oxide 57%
• Microtubules 57%
• Colchicine 57%
• Nocodazole 57%
• Nitric Oxide Signaling 57%
• Endothelial Cells 42%
• Smooth muscle Cells 42%
• Cyclic GMP 42%
• Microfilaments 42%
• Inhibitory Effect 28%
• Endotoxin 28%
• Taxol 28%
• Inducible Nitric Oxide 28%
• Isozymes 14%
• Macrophages 14%
• Inflammatory Mediators 14%
• Vascular Cells 14%
• Quantitative PCR 14%
• Interleukin-1β 14%
• Western Blotting 14%
• Lipopolysaccharide 14%
• Septic Shock 14%
• MRNA Level 14%
• Vascular Smooth muscle Cells 14%
• Steady State 14%
• Cardiovascular Collapse 14%
• Smooth muscle 14%
• Cardiovascular Homeostasis 14%
• Northern Blot 14%
• Microtubule Assembly 14%
• Shock Therapy 14%
• Vascular Endothelial 14%
• Antitumor Therapy 14%
• Depolymerization 14%
• Cell Modulation 14%
• Microtubule Depolymerization 14%
• Microtubule Polymerization 14%
• Cytochalasin 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Nitric Oxide 100%
• Inducible Nitric Oxide Synthase 100%
• Colchicine 50%
• Nocodazole 50%
• Cytokine 37%
• Cyclic GMP 37%
• Nitric Oxide Synthase 25%
• Endotoxin 25%
• Paclitaxel 25%
• Messenger RNA 25%
• Western Blot 12%
• Lipopolysaccharide 12%
• Septic Shock 12%
• Shock 12%
• Interleukin 1 12%
• Cytochalasin 12%
• Isoenzyme 12%